NCT03718624 2018-10-31
A Study of Intraperitoneal and Intravenous Paclitaxel Plus Apatinib and S-1 Conversion Therapy for Gastric Cancer With Positive Exfoliative Cancer Cells
Hebei Medical University
Phase 2 Unknown
Clinical Trials
1 trialsGastric Cancer With Positive Exfoliative Cancer Cells × S 1 (combination) × Gastrointestinal × Clear all